Jos Jonkers
Jos Jonkers
Group Leader and Head of Division of Molecular Pathology, Netherlands Cancer Institute
Verified email at nki.nl - Homepage
TitleCited byYear
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers, R Meuwissen, H van der Gulden, H Peterse, M van der Valk, ...
Nature genetics 29 (4), 418, 2001
9042001
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47, 2016
7712016
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
S Rottenberg, JE Jaspers, A Kersbergen, E van der Burg, AOH Nygren, ...
Proceedings of the National Academy of Sciences 105 (44), 17079-17084, 2008
7242008
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
P Bouwman, A Aly, JM Escandell, M Pieterse, J Bartkova, ...
Nature structural & molecular biology 17 (6), 688, 2010
6922010
Patient-derived xenograft models: an emerging platform for translational cancer research
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
6792014
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
S Marino, M Vooijs, H van der Gulden, J Jonkers, A Berns
Genes & development 14 (8), 994-1004, 2000
6572000
The ins and outs of lysophosphatidic acid signaling
WH Moolenaar, LA van Meeteren, BNG Giepmans
Bioessays 26 (8), 870-881, 2004
6002004
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells
A Loonstra, M Vooijs, HB Beverloo, B Al Allak, E van Drunen, R Kanaar, ...
Proceedings of the National Academy of Sciences 98 (16), 9209-9214, 2001
5622001
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
SB Coffelt, K Kersten, CW Doornebal, J Weiden, K Vrijland, CS Hau, ...
Nature 522 (7556), 345, 2015
5502015
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
PWB Derksen, X Liu, F Saridin, H van der Gulden, J Zevenhoven, B Evers, ...
Cancer cell 10 (5), 437-449, 2006
5412006
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
LA Van Meeteren, P Ruurs, C Stortelers, P Bouwman, MA van Rooijen, ...
Molecular and cellular biology 26 (13), 5015-5022, 2006
4952006
Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt‐mediated regulation of LEF‐1
L Li, H Yuan, CD Weaver, J Mao, GH Farr, DJ Sussman, J Jonkers, ...
The EMBO journal 18 (15), 4233-4240, 1999
4601999
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways
MC Boelens, TJ Wu, BY Nabet, B Xu, Y Qiu, T Yoon, DJ Azzam, ...
Cell 159 (3), 499-513, 2014
3932014
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
P Bouwman, J Jonkers
Nature Reviews Cancer 12 (9), 587, 2012
3882012
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
X Liu, H Holstege, H van der Gulden, M Treur-Mulder, J Zevenhoven, ...
Proceedings of the National Academy of Sciences 104 (29), 12111-12116, 2007
3572007
A highly efficient ligand‐regulated Cre recombinase mouse line shows that LoxP recombination is position dependent
M Vooijs, J Jonkers, A Berns
EMBO reports 2 (4), 292-297, 2001
3262001
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors
H Mikkers, M Nawijn, J Allen, C Brouwers, E Verhoeven, J Jonkers, ...
Molecular and cellular biology 24 (13), 6104-6115, 2004
3092004
Conditional mouse models of sporadic cancer
J Jonkers, A Berns
Nature Reviews Cancer 2 (4), 251, 2002
3062002
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
S Rottenberg, AOH Nygren, M Pajic, FWB van Leeuwen, ...
Proceedings of the National Academy of Sciences 104 (29), 12117-12122, 2007
2982007
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors
JE Jaspers, A Kersbergen, U Boon, W Sol, L Van Deemter, SA Zander, ...
Cancer discovery 3 (1), 68-81, 2013
2842013
The system can't perform the operation now. Try again later.
Articles 1–20